BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11025778)

  • 1. The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP.
    Leach FS; Velasco A; Hsieh JT; Sagalowsky AI; McConnell JD
    J Urol; 2000 Nov; 164(5):1830-3. PubMed ID: 11025778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.
    Leach FS; Hsieh JT; Molberg K; Saboorian MH; McConnell JD; Sagalowsky AI
    Cancer; 2000 May; 88(10):2333-41. PubMed ID: 10820356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel germline hMSH2 genomic deletion and somatic hMSH2 mutations in a hereditary nonpolyposis colorectal cancer family.
    Miyaki M; Iijima T; Yamaguchi T; Shirahama S; Ito T; Yasuno M; Mori T
    Mutat Res; 2004 Apr; 548(1-2):19-25. PubMed ID: 15063132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
    Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
    Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic?
    Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M
    Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy.
    Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S
    Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity.
    Risinger JI; Umar A; Boyer JC; Evans AC; Berchuck A; Kunkel TA; Barrett JC
    Cancer Res; 1995 Dec; 55(23):5664-9. PubMed ID: 7585651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of hMSH2 expression in primary breast cancer with p53 alterations.
    Spagnoletti I; Pizzi C; Galietta A; Di Maio M; Mastranzo P; Daniele S; Limite G; Pettinato G; Contegiacomo A
    Oncol Rep; 2004 Apr; 11(4):845-51. PubMed ID: 15010883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer.
    Prtilo A; Leach FS; Markwalder R; Kappeler A; Burkhard FC; Cecchini MG; Studer UE; Thalmann GN
    J Urol; 2005 Nov; 174(5):1814-8; discussion 1818. PubMed ID: 16217293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
    Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
    Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite instability and mismatch repair target gene mutations in cell lines and xenografts of prostate cancer.
    Sun X; Chen C; Vessella RL; Dong JT
    Prostate; 2006 May; 66(6):660-6. PubMed ID: 16388502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6.
    Umar A; Koi M; Risinger JI; Glaab WE; Tindall KR; Kolodner RD; Boland CR; Barrett JC; Kunkel TA
    Cancer Res; 1997 Sep; 57(18):3949-55. PubMed ID: 9307278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic analysis of hMSH2 mutations in mouse cells carrying human chromosomes.
    Marra G; D'Atri S; Yan H; Perrera C; Cannavo' E; Vogelstein B; Jiricny J
    Cancer Res; 2001 Nov; 61(21):7719-21. PubMed ID: 11691782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues.
    Leach FS; Polyak K; Burrell M; Johnson KA; Hill D; Dunlop MG; Wyllie AH; Peltomaki P; de la Chapelle A; Hamilton SR; Kinzler KW; Vogelstein B
    Cancer Res; 1996 Jan; 56(2):235-40. PubMed ID: 8542572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonic cancer in a 34-yr-old woman: should it prompt microsatellite instability studies and mismatch repair gene testing?
    Claro I; Cravo M; Glória L; Gaspar C; Albuquerque C; Lage P; Fidalgo P; Ramalho E; Chaves P; Cardoso P; Nobre Leitão C
    Am J Gastroenterol; 1998 Oct; 93(10):1991-2. PubMed ID: 9772075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of DNA microsatellite loci in salivary gland tumours: comparison with immunohistochemical detection of hMSH2 and p53 proteins.
    Ohki K; Kumamoto H; Ichinohasama R; Suzuki M; Yamaguchi T; Echigo S; Motegi K; Ooya K
    Int J Oral Maxillofac Surg; 2001 Dec; 30(6):538-44. PubMed ID: 11829237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of hMSH2 and DNA polymerase beta genes in breast carcinomas and fibroadenomas.
    Bhattacharyya N; Chen HC; Grundfest-Broniatowski S; Banerjee S
    Biochem Biophys Res Commun; 1999 Jun; 259(2):429-35. PubMed ID: 10362525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human mismatch repair gene (hMSH2) product expression in relation to recurrence of transitional cell carcinoma of the urinary bladder.
    Jin TX; Furihata M; Yamasaki I; Kamada M; Liang SB; Ohtsuki Y; Shuin T
    Cancer; 1999 Jan; 85(2):478-84. PubMed ID: 10023718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence.
    Velasco A; Hewitt SM; Albert PS; Hossein M; Rosenberg H; Martinez C; Sagalowsky AI; McConnell JD; Marston W; Leach FS
    Cancer; 2002 Feb; 94(3):690-9. PubMed ID: 11857301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.